These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31781311)

  • 41. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.
    Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J
    BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
    Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
    J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer.
    Zhang Z; Wang S; Liu Y; Meng Z; Chen F
    Oncol Rep; 2019 Sep; 42(3):1110-1124. PubMed ID: 31322274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
    Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
    J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
    Jiao Y; Li Y; Jia B; Chen Q; Pan G; Hua F; Liu Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31967298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hu Q; Shen S; Li J; Liu L; Liu X; Zhang Y; Zhou Y; Zhu W; Yu Y; Cui G
    Dis Markers; 2020; 2020():3231273. PubMed ID: 32733617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. m
    Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H
    Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.
    Zhang YP; Bao ZW; Wu JB; Chen YH; Chen JR; Xie HY; Zhou L; Wu J; Zheng SS
    Technol Cancer Res Treat; 2020; 19():1533033820944274. PubMed ID: 32715976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.
    Jiang X; Peng J; Xie Y; Xu Y; Liu Q; Cheng C; Yan P; Xu S; Wang Y; Zhang L; Li H; Li Y; Li B; Han J; Yu D
    Cell Death Differ; 2023 Aug; 30(8):1931-1942. PubMed ID: 37419985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.